Drug Safety Data

Author: Michael J. Klepper
Edition: 1
Binding: Paperback
ISBN: 0763769126

Drug Safety Data: How to Analyze, Summarize, and Interpret to Determine Risk

Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk was selected for The First Clinical Research Bookshelf - Essential reading for clinical research professionals by the Journal of Clinical Research Best Practices. Download Drug Safety Data: How to Analyze, Summarize, and Interpret to Determine Risk from rapidshare, mediafire, 4shared. Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk provides drug safety/pharmacovogilance professionals, pharmaceutical and clinical research scientists, statisticians, programmers, medical writers, and technicians with an accessible, practical framework for the analysis, summary and interpretation of drug safety data. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk Search and find a lot of engineering books in many category availabe for free download.

Download Drug Safety Data

Download Drug Safety Data engineering books for free. The only guide of its kind, Drug Safety Data: How to Analyze, Summarize and Interpret to Determine Risk is an invaluable reference for pre- and post-marketing risk

Other engineering books

Cobert's Manual of Drug Safety and Pharmacovigilance

Completely revised and updated, the Manual of Drug Safety and Pharmacovigilance, Second Edition is a how-to manual for those working in the fields of drug safety, clinical research, pharmacology, regulatory affairs, government and legal professions.

Pharmacovigilance Medical Writing: A Good Practice Guide

Pharmacovigilance Medical WritingAcovers the preparation of pharmacovigilance documents for all stages of the drug development process (i.e. from clinical development through to applications for marketing authorisations to the post-marketing

Practical Aspects of Signal Detection in Pharmacovigilance: Report of CIOMS Working Group VIII (CIOMS Nonserial)

In recent years public expectations for rapid identification and prompt management of emerging drug safety issues have grown swiftly. Over a similar timeframe, the move from paper-based adverse event reporting systems to electronic capture and rapid